| Primary |
| Hiv Infection |
85.8% |
| Drug Use For Unknown Indication |
3.8% |
| Atrial Fibrillation |
1.2% |
| Prophylaxis |
1.2% |
| Systemic Antiviral Treatment |
1.2% |
| Depression |
1.0% |
| Product Used For Unknown Indication |
0.9% |
| Cerebral Toxoplasmosis |
0.6% |
| Hiv Infection Cdc Category B3 |
0.6% |
| Hiv Infection Cdc Category C3 |
0.6% |
| Epilepsy |
0.4% |
| Infection Prophylaxis |
0.4% |
| Affective Disorder |
0.3% |
| Bronchopulmonary Disease |
0.3% |
| Hepatitis C |
0.3% |
| Hiv Infection Cdc Category B2 |
0.3% |
| Hypertension |
0.3% |
| Hypothyroidism |
0.3% |
| Pulmonary Arterial Hypertension |
0.3% |
| Vaginal Infection |
0.3% |
|
| Hepatotoxicity |
14.8% |
| Death |
8.0% |
| Transaminases Increased |
8.0% |
| Myositis |
6.8% |
| Rhabdomyolysis |
5.7% |
| Vomiting |
5.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.5% |
| Premature Baby |
4.5% |
| Skin Disorder |
4.5% |
| Umbilical Hernia |
4.5% |
| Hepatic Enzyme Increased |
3.4% |
| Pancreatitis Acute |
3.4% |
| Rash |
3.4% |
| Rash Generalised |
3.4% |
| Septic Shock |
3.4% |
| Skin Exfoliation |
3.4% |
| Tachyphrenia |
3.4% |
| Urticaria |
3.4% |
| Weight Decreased |
3.4% |
| Anaemia |
2.3% |
|
| Secondary |
| Hiv Infection |
64.8% |
| Depression |
5.0% |
| Product Used For Unknown Indication |
4.8% |
| Drug Use For Unknown Indication |
4.7% |
| Atrial Fibrillation |
3.6% |
| Prophylaxis Against Hiv Infection |
2.2% |
| Hiv Test Positive |
1.9% |
| Trigeminal Neuralgia |
1.7% |
| Pulmonary Hypertension |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Hyperlipidaemia |
1.3% |
| Contusion |
1.2% |
| Anxiety |
1.0% |
| Systemic Antiviral Treatment |
1.0% |
| Drug Exposure During Pregnancy |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Arthralgia |
0.6% |
| Contraception |
0.6% |
| Hiv Infection Cdc Category C3 |
0.6% |
| Cerebral Toxoplasmosis |
0.5% |
|
| Hepatotoxicity |
8.4% |
| Myocardial Infarction |
8.4% |
| Myositis |
7.2% |
| Thrombocytopenia |
7.2% |
| Urticaria |
7.2% |
| Vomiting |
7.2% |
| Cytolytic Hepatitis |
6.0% |
| Skin Ulcer |
6.0% |
| Ventricular Arrhythmia |
6.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.8% |
| Death |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Drug Resistance |
3.6% |
| Impaired Work Ability |
3.6% |
| Neutropenia |
3.6% |
| Weight Decreased |
3.6% |
| Coagulation Factor Deficiency |
2.4% |
| Cystitis Haemorrhagic |
2.4% |
| Gastrointestinal Disorder |
2.4% |
| Hypoaesthesia |
2.4% |
|
| Concomitant |
| Hiv Infection |
70.5% |
| Drug Use For Unknown Indication |
6.1% |
| Infection |
3.0% |
| Hepatitis B |
2.7% |
| Hepatitis C |
2.3% |
| Product Used For Unknown Indication |
2.1% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Mixed Hyperlipidaemia |
1.5% |
| Antiretroviral Therapy |
1.3% |
| Drug Exposure During Pregnancy |
1.1% |
| Prophylaxis |
1.1% |
| Antifungal Prophylaxis |
0.9% |
| Cerebral Toxoplasmosis |
0.8% |
| Ear Pain |
0.8% |
| Headache |
0.8% |
| Herpes Virus Infection |
0.8% |
| Hiv Test Positive |
0.8% |
| Induction Of Anaesthesia |
0.8% |
| Anaemia Of Chronic Disease |
0.6% |
| Arthralgia |
0.6% |
|
| Osteonecrosis |
6.9% |
| Pancreatitis |
6.9% |
| Pyrexia |
6.9% |
| Varices Oesophageal |
6.9% |
| Weight Decreased |
6.9% |
| Autoimmune Thyroiditis |
5.2% |
| Emphysema |
5.2% |
| Polyarteritis Nodosa |
5.2% |
| Rash Erythematous |
5.2% |
| Rash Generalised |
5.2% |
| Renal Colic |
5.2% |
| Renal Failure Acute |
5.2% |
| Weight Increased |
5.2% |
| Death |
3.4% |
| Disturbance In Attention |
3.4% |
| Glomerular Filtration Rate Decreased |
3.4% |
| Jaundice Cholestatic |
3.4% |
| Metastatic Neoplasm |
3.4% |
| Myalgia |
3.4% |
| Myocardial Infarction |
3.4% |
|
| Interacting |
| Hiv Infection |
91.7% |
| Hodgkin's Disease |
8.3% |
|
| Mental Disorder Due To A General Medical Condition |
33.3% |
| Osteonecrosis |
33.3% |
| Underdose |
33.3% |
|
